Kevin Young to present Gilad at NASDAQ OMX 23rd Investor Program

Tuesday December 1, 2009 Kevin Young, Gilead’s Executive Vice President of Commercial Operations, will provide an overview of the company at the NASDAQ OMX Investor Program.  This will be available for viewing on Gilad’s website and it will benefit those who are interested in learning more about this company and this company’s goals for the future.

Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website

About Best Damn Penny Stocks

Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.